[1]孙重,张莹,吴作红,等.P50和P200型 Ex-PRESS青光眼引流钉治疗原发性开角型青光眼的疗效及安全性对比[J].眼科新进展,2021,41(2):162-165.[doi:10.13389/j.cnki.rao.2021.0034]
　SUN Zhong,ZHANG Ying,WU Zuohong,et al.Comparison of the therapeutic efficacy and safety of P50 and P200 Ex-PRESS miniature glaucoma device implantation for primary open-angle glaucoma[J].Recent Advances in Ophthalmology,2021,41(2):162-165.[doi:10.13389/j.cnki.rao.2021.0034]
点击复制

P50和P200型 Ex-PRESS青光眼引流钉治疗原发性开角型青光眼的疗效及安全性对比/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年2期
页码:
162-165
栏目:
应用研究
出版日期:
2021-02-05

文章信息/Info

Title:
Comparison of the therapeutic efficacy and safety of P50 and P200 Ex-PRESS miniature glaucoma device implantation for primary open-angle glaucoma
作者:
孙重; 张莹; 吴作红; 周和政
430060　湖北省武汉市，武汉大学附属爱尔眼科医院
Author(s):
SUN Zhong; ZHANG Ying; WU Zuohong; ZHOU Hezheng
Aier Eye Hospital of Wuhan University,Wuhan 430060，Hubei Province，China
关键词:
Ex-PRESS青光眼引流钉植入术; 原发性开角型青光眼; 眼压; 治疗效果; 术后并发症
Keywords:
Ex-PRESS miniature glaucoma device implantation;  primary open-angle glaucoma;  intraocular pressure;  treatment outcome;  postoperative complications
分类号:
R775
DOI:
10.13389/j.cnki.rao.2021.0034
文献标志码:
A
摘要:
目的　对比P50型和P200型 Ex-PRESS青光眼引流钉治疗原发性开角型青光眼（POAG)的疗效及安全性。方法　选取2016年5月至2018年12月在武汉大学附属爱尔眼科医院住院的POAG患者32例(32眼)作为研究对象。采用随机数字表法将患者分为P50组和P200组，每组16例（16眼），分别行P50型和P200型Ex-PRESS青光眼引流钉植入术。术后随访12个月，观察各组眼压、最佳矫正视力、手术成功率、并发症发生情况。结果　P50组和P200组患者术后1周、1个月、3个月、6个月、12个月眼压均低于术前，差异均有统计学意义（均为P<0.05）；两组患者间术前及术后1周、1个月、3个月、6个月、12个月眼压相比，差异均无统计学意义(均为P>0.05)。术后12个月P50组和P200组患者最佳矫正视力分别为4.33±0.26、4.14±0.59，均较术前轻微下降，但差异均无统计学意义(均为P>0.05)；术后12个月两组患者最佳矫正视力比较，差异亦无统计学意义 (t=1.67,P>0.05)。术后1周、1个月、3个月两组患者手术完全成功率均为100.0%；术后6个月，P50组手术完全成功率为87.5%，P200组为93.8%，两组差异无统计学意义（χ2=0.367 7,P>0.05）；术后12 个月,P50组手术完全成功率为75.0%，P200组为87.5%，两组差异无统计学意义（χ2=0.820 5,P>0.05）。术后12个月,P50组出现滤过泡包裹8眼，P200组3眼，差异有统计学意义（P<0.05）；其中，P50组4眼、P200组2眼通过针刺分离联合5-氟尿嘧啶注射后滤过道恢复通畅。结论　P50型和P200型Ex-PRESS青光眼引流钉植入术均能有效治疗POAG，而P200型青光眼引流钉植入术后晚期滤过泡包裹发生率较低。
Abstract:
Objective　To compare the efficacy and safety of P50 and P200 Ex-PRESS miniature glaucoma device implantation for primary open-angle glaucoma (POAG).Methods　Totally 32 eyes from 32 POAG patients were performed from May 2016 to December 2018 in Aier eye hospital of Wuhan university．The patients were randomized into 2 groups（P50 and P200）according to randomized digital table，16 patients in each group were implanted with either P50 or P200 Ex-PRESS miniature glaucoma device respectively. All patients were followed up for 12 months to compare the intraocular pressure, best corrected visual acuity, success rate and complications.Results　In P50 group and P200 group, the postoperative intraocular pressure at 1 week, 1 month, 3 months, 6 months and 12 months were lower than preoperative intraocular pressure, and the differences were statistically significant (all P<0.05). There was no statistically significant difference in intraocular pressure between the two groups at preoperation and 1 week, 1 month, 3 months, 6 months and 12 months postoperation (all P>0.05). The average best corrected visual acuity of the two groups was 4.33 ± 0.26 versus 4.14±0.59 at 12 months postoperation, with slight decrease, but there was no significant difference between preoperation and postoperation (P>0.05). There was no statistically significant difference in average best corrected visual acuity between the two groups at 12 months postoperation (t=1.67, P>0.05). In the two groups, complete success rate of the operation was 100.0% at 1 week, 1 month and 3 months postoperation. Complete success rate of the operation was 87.5% in P50 group versus 93.8% in P200 group at 6 months postoperation, and the difference was no statistically significant (χ2=0.367 7, P>0.05). Complete success rate of the operation was 75.0% in P50 group versus 87.5% in P200 group at 12 months postoperation, and the difference was no statistically significant (χ2=0.820 5, P>0.05). Encapsulated bleb occurred in both groups at 12 months postoperation, and 8 eyes in P50 group and 3 eyes in P200 group,the difference was statistally significant（P<0.05）. The blebs of 4 eyes in P50 group and 2 eyes in P200 group were revisited by acupuncture separation combined with 5-Fu injection.Conclusion　Ex-PRESS P50 and P200 miniature glaucoma device implantation can effectively treat POAG, but the incidence of encapsulated bleb in the late period after P200 miniature glaucoma device implantation is low.

参考文献/References:

［1］　SALIM S.The role of the Ex-PRESS glaucoma filtration device in glaucoma surgery［J］.Semin Ophthalmol,2013,28(3)：180-184.
［2］　ROUSE J M,SARKISIAN S J．Mini-drainage devices：the Ex-PRESS mini-glaucoma device［J］．Dev Ophthalmol,2012,17(1)：90-95．
［3］　ESTERMANN S，YUTTITHAM K，CHEN J A，STAMPER R.Comparative in vitro flow study of 3 different Ex-PRESS miniature glaucoma device models［J］.J Glaucoma，2013，22(3)：209-214．
［4］　SARKISIAN S R．Tube shunt complication and their prevention［J］．Curr Opin Ophthalmol,2009,20(2):126-130．
［5］　DAHAN E，BEN SIMON G J，LAFUMA A.Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient：a prospective,randomised study［J］.Eye，2012，26(5)：703-710.
［6］　SEIDER M I,ROFAGHA S,LIN S C,STAMPER R．Resident-performed Ex-PRESS shunt implantation versus trabeculectomy［J］.J Glaucoma,2012,21(7)：469-474．
［7］　BUYS Y M．Trabeculectomy versus Ex-PRESS shunt surgery in residency training［J］.Surv Ophthalmol,2012,57(4)：375-378．
［8］　王越,柯敏,韩芳芳,王文欢，翁鸿.Ex-PRESS引流器植入术与小梁切除术治疗开角型青光眼有效性和安全性的Meta分析［J］.山东大学耳鼻喉眼学报,2017,31(2):104-111.
WANG Y,KE M，HAN F F,WANG W H,WENG H．Efficacy and safety of Ex-PRESS implanation versus trabeculectomy for open-angle glaucoma：a meta-analysis［J］.J Otolaryngol Ophthal Shandong Univ,2017,31(2):104-111.
［9］　GILLES B,JONG D,ANTOINE L,AGUADE A S.Five-year extension of a clinical trial comparing the Ex-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma［J］.Clin Ophthalmol,2011,5(3):527-533．
［10］　CASINI G,LOIUDICE P,PELLEGRINI M,SFRAMELI A T,MARTINELLI P,PASSANI A,et al.Trabeculectomy versus Ex-PRESS shunt versus ahmed valve implant:short-term effects on corneal endothelial cells［J］.Am J Ophthalmol,2015,160(6):1185-1190.

相似文献/References:

[1]陈慧 胡义珍 柯晓云 陈晓虹.睾酮诱导牛眼小梁细胞组织型谷氨酰胺转移酶的表达[J].眼科新进展,2012,32(11):000.
[2]董敬民 张效房 马跃伟 王卫群 孔令训.曲伏前列素治疗原发性开角型青光眼的临床研究[J].眼科新进展,2012,32(12):000.
[3]唐浩英 王璟 卢敏.细胞外钙离子内流上调原发性开角型青光眼患者小梁网细胞Copine1表达的研究[J].眼科新进展,2013,33(8):000.
[4]鲍炯琳 林文雄 曾泳辉 李青 孙丽 王文娟 罗焕然 臧晶.真空小梁成形术治疗原发性开角型青光眼[J].眼科新进展,2012,32(8):000.
[5]徐静 李雪 胡琦 杨帆 吴琼 王珂萌.超高度近视眼屈光力及眼轴影响因素分析[J].眼科新进展,2012,32(10):000.
[6]谢瞻 袁志兰.不同手术方式对POAG患者情绪及生存质量影响的比较[J].眼科新进展,2013,33(5):000.
[7]陆炯 孟逸芳 陶建军 邢茜 顾正.光学相干断层扫描在检测原发性开角型青光眼早期视网膜神经纤维层厚度变化中的应用[J].眼科新进展,2013,33(11):000.
[8]周晓芳,付汛安,李双.超声乳化白内障吸出联合ExPRESS青光眼引流器植入术治疗合并白内障的原发性开角型青光眼[J].眼科新进展,2014,34(6):554.[doi:10.13389/j.cnki.rao.2014.0151]
[9]张敏,王强,王康. 糖基化终末产物对体外培养牛眼小梁细胞氧化应激及凋亡的影响[J].眼科新进展,2014,34(7):640.[doi:10.13389/j.cnki.rao.2014.0175]
[10]叶汉元,曾云,李鸿翎.EX-PRESS青光眼引流器植入术治疗原发性开角型青光眼[J].眼科新进展,2015,35(1):059.[doi:10.13389/j.cnki.rao.2015.0017]
　YE Han-Yuan,ZENG Yun,LI Hong-Ling.EX-PRESS glaucoma filtration device implantation for primary open angle glaucoma[J].Recent Advances in Ophthalmology,2015,35(2):059.[doi:10.13389/j.cnki.rao.2015.0017]

备注/Memo

备注/Memo:
武汉市临床医学（西医药类）科研项目（编号：WX16Z02）
更新日期/Last Update: 2021-02-05